GCM
MEDP icon

Graham Capital Management’s Medpace MEDP Stock Holding History

Graham Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Sell
839
-339
-29% -$156K 0.01% 752
2026
Q1 		$566K Sell
1,178
-262
-18% -$134K 0.01% 588
2025
Q4 		$809K Buy
+1,440
New +$817K 0.02% 449
2025
Q3 		– Sell
-1,655
Closed -$519K – 1486
2025
Q2 		$519K Buy
1,655
+555
+50% +$167K 0.01% 801
2025
Q1 		$335K Sell
1,100
-132
-11% -$44.4K 0.01% 953
2024
Q4 		$409K Sell
1,232
-1,481
-55% -$502K 0.01% 815
2024
Q3 		$906K Buy
2,713
+432
+19% +$164K 0.02% 492
2024
Q2 		$939K Sell
2,281
-389
-15% -$154K 0.02% 435
2024
Q1 		$1.08M Buy
2,670
+984
+58% +$346K 0.02% 404
2023
Q4 		$517K Buy
+1,686
New +$455K 0.01% 580
2023
Q3 		– Sell
-7,702
Closed -$1.85M – 1190
2023
Q2 		$1.85M Sell
7,702
-4,002
-34% -$831K 0.05% 230
2023
Q1 		$2.2M Sell
11,704
-4,385
-27% -$907K 0.07% 228
2022
Q4 		$3.42M Buy
16,089
+3,069
+24% +$613K 0.1% 116
2022
Q3 		$2.05M Buy
+13,020
New +$2.08M 0.08% 222
2022
Q1 		– Sell
-1,052
Closed -$228K – 969
2021
Q4 		$228K Buy
+1,052
New +$220K 0.01% 419

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Graham Capital Management's MEDP Position: Q2 2026 in Review

Graham Capital Management reduced its Medpace (MEDP) stake by 29% in Q2 2026, selling an estimated $156K and leaving 839 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #752.

Graham Capital Management first reported a position in MEDP in Q4 2021 and has held it in 15 quarters since. The position peaked at $3.42M in Q4 2022. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Graham Capital Management held 839 shares of Medpace worth $444K as of Q2 2026.
  • Graham Capital Management sold 339 Medpace shares in Q2 2026, an estimated $156K.
  • Medpace made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #752 holding.
  • Graham Capital Management first reported a position in Medpace in Q4 2021 and has held it in 15 quarters since.
  • Graham Capital Management's Medpace position peaked at $3.42M in Q4 2022.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.